Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR650167

27325e82-4183-526c-95c7-dde9f0bc7f97

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
sex
Male

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • MITOTIC_SPINDLE+0.120
  • NOTCH_SIGNALING+0.090
  • DNA_REPAIR+0.060
  • SPERMATOGENESIS+0.060
  • MYC_TARGETS_V2+0.000
  • GLYCOLYSIS-0.040
  • PROTEIN_SECRETION-0.040
  • ESTROGEN_RESPONSE_EARLY-0.060
  • P53_PATHWAY-0.060
  • MYC_TARGETS_V1-0.070

Top 10 suppressed

  • TNFA_SIGNALING_VIA_NFKB-0.590
  • ALLOGRAFT_REJECTION-0.540
  • IL6_JAK_STAT3_SIGNALING-0.540
  • INFLAMMATORY_RESPONSE-0.500
  • INTERFERON_GAMMA_RESPONSE-0.500
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.470
  • INTERFERON_ALPHA_RESPONSE-0.460
  • COMPLEMENT-0.440
  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.410
  • IL2_STAT5_SIGNALING-0.380

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

2 twins match this tumor's tissue · 8 come from a different tissue of origin ← cross-tissue dominant

#SampleCancer typeSubtypecos similarity
1SRR1364800
brain-umap@2
GTEX0.919
2SRR607967
brain-umap@2
GTEX0.911
3SRR8613756
breast-umap@18
E0.909
4SRR1441224
brain-umap@2
GTEX0.908
5SRR650132
bladder-landscape@3
0.908
6SRR1324452
brain-umap@2
GTEX0.907
7SRR1459033
brain-umap@2
GTEX0.906
8SRR1322010
brain-umap@2
GTEX0.905
9MDT-AP-0189
medullo-epn-umap@date-based
MedMedulloblastoma0.905
10SRR1433644
brain-umap@2
GTEX0.904

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 4 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
MITOTIC_SPINDLE0.120Inavolisib— uncovered
NOTCH_SIGNALING0.090Inavolisib— uncovered
DNA_REPAIR0.060Idelalisib— uncovered
SPERMATOGENESIS0.060Inavolisib— uncovered